PMID: 488497Jan 1, 1979Paper

Clinic and treatment of porphyria cutanea tarda (author's transl)

Dermatologica
G Goerz

Abstract

Symptomatology and pathogenesis of porphyria cutanea tarda (PCT) are shortly reviewed. The different possibilities in the treatment of PCT are discussed with special reference to the phlebotomy according to Ippen and to the chloroquine administration according to the regimen described by Kordac and Semradova in 1974. 75 PCT patients were treated with chloroquine (Resochin, Nivaquine). After 9.3 +/- 3.4 months (means +/- SE) all patients excreted normal amounts of porphyrins, and the clinical symptoms disappeared. 14 of these patients relapsed after a mean period of 21 months after the withdrawal of chloroquine.

Related Concepts

Related Feeds

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Related Papers

Medicina clínica
C Fernández-MirandaR Enriquez de Salamanca
The British Journal of Dermatology
G Swanbeck, G Wennersten
Dermatology : International Journal for Clinical and Investigative Dermatology
Christine ChiavériniJean-Philippe Lacour
Journal of the American Academy of Dermatology
C S Petersen, K Thomsen
© 2021 Meta ULC. All rights reserved